| Stage | BKR | % of rev | INVX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $8.0B | 100.00% | $265M | 100.00% | BKR ×30.28 |
| Gross profit | $1.9B | 24.02% | $96M | 36.17% | INVX +12.1pp |
| Operating income | $853M | 10.63% | $32M | 12.20% | INVX +1.6pp |
| Pre-tax income | $519M | 6.47% | $35M | 13.12% | INVX +6.7pp |
| Net income | $422M | 5.26% | $26M | 9.92% | INVX +4.7pp |
| Stage | BKR | INVX | Gap · A − B |
|---|---|---|---|
| Revenue | $8.0B100.00% | $265M100.00% | BKR ×30.28 |
| Gross profit | 24.02%$1.9B | 36.17%$96M | INVX +12.1pp |
| Operating income | 10.63%$853M | 12.20%$32M | INVX +1.6pp |
| Pre-tax income | 6.47%$519M | 13.12%$35M | INVX +6.7pp |
| Net income |
| 5.26%$422M |
| 9.92%$26M |
| INVX +4.7pp |
No shared counterparties.